Literature DB >> 10506678

Low-dose subcutaneous ketamine infusion and morphine tolerance.

R F Bell1.   

Abstract

The NMDA receptor has been reported to be involved in opioid tolerance. Adjuvant subcutaneous infusion treatment with (very) low-dose ketamine, a NMDA receptor antagonist, improves analgesia and at the same time appears to reduce morphine tolerance. Three cases are presented.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10506678     DOI： 10.1016/s0304-3959(99)00096-2

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


  18 in total

1.  Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.

Authors:  Michael E Goldberg; Marc C Torjman; Robert J Schwartzman; Donald E Mager; Irving W Wainer
Journal:  Pain Physician       Date:  2010 Jul-Aug       Impact factor: 4.965

Review 2.  Advances in translational neuropathic research: example of enantioselective pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief in complex regional pain syndrome.

Authors:  Michael Sabia; Robert A Hirsh; Marc C Torjman; Irving W Wainer; Niti Cooper; Richard Domsky; Michael E Goldberg
Journal:  Curr Pain Headache Rep       Date:  2011-06

3.  Acute effect of essential oil of Eugenia caryophyllata on cognition and pain in mice.

Authors:  Sumita Halder; Ashish K Mehta; Pramod K Mediratta; Krishna K Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-28       Impact factor: 3.000

Review 4.  Ketamine as an adjuvant to opioids for cancer pain.

Authors:  Rae F Bell; Christopher Eccleston; Eija A Kalso
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

Review 5.  Clinically important drug interactions with intravenous anaesthetics in older patients.

Authors:  Helge Eilers; Claus Niemann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Blockade of NMDA receptors prevents analgesic tolerance to repeated transcutaneous electrical nerve stimulation (TENS) in rats.

Authors:  Priyanka M Hingne; Kathleen A Sluka
Journal:  J Pain       Date:  2007-12-03       Impact factor: 5.820

7.  Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1.

Authors:  Reza N Sharif; Michael Osborne; Terence J Coderre; Marian E Fundytus
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

8.  The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity.

Authors:  Keith A Trujillo
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 9.  Tolerance and withdrawal from prolonged opioid use in critically ill children.

Authors:  Kanwaljeet J S Anand; Douglas F Willson; John Berger; Rick Harrison; Kathleen L Meert; Jerry Zimmerman; Joseph Carcillo; Christopher J L Newth; Parthak Prodhan; J Michael Dean; Carol Nicholson
Journal:  Pediatrics       Date:  2010-04-19       Impact factor: 7.124

10.  Nimodipine potentiates the analgesic effect of morphine in the rat hot-plate test: Implications in the treatment of pain.

Authors:  Rakesh Kumar; Sagolshem S Singh; Subrata Basu Ray
Journal:  Indian J Anaesth       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.